M26.71
Alveolar maxillary hyperplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Alveolar maxillary hyperplasia is a condition characterized by abnormal overgrowth of the maxillary alveolar process—the part of the upper jaw that holds the teeth. This condition can lead to noticeable facial changes and dental issues, often requiring assessment and management by dental or maxillofacial specialists. Although rare, understanding its features helps in recognizing the importance of early diagnosis and treatment options.
Causes & Symptoms
Clinical Causes: Genetic factors influencing bone growth and development Chronic inflammation or infection affecting the maxillary region Certain hormonal imbalances that promote abnormal bone growth Trauma or injury to the facial bones during development Developmental anomalies present from birth
Key Symptoms: Visible swelling or enlargement of the upper jaw region Misalignment or malocclusion of upper teeth Difficulty in fitting dentures or other dental appliances Pain or discomfort in the affected area Swelling may be tender or firm upon touch Altered facial symmetry
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical examination, patient history assessment, and imaging studies such as panoramic X-rays or CT scans. These imaging tools help in evaluating the extent of bone overgrowth and ruling out other jaw or dental conditions. Sometimes, biopsy may be performed if tissue samples are needed to exclude other pathologies.
Treatment Protocols: Management of alveolar maxillary hyperplasia depends on severity and associated symptoms. Common approaches include: - Surgical intervention to remove excess bone tissue if necessary - Orthodontic treatment to correct dental misalignment - Regular monitoring to observe disease progression - Addressing any underlying causes, such as infections or hormonal issues In some cases, conservative observation may suffice if the overgrowth is mild or asymptomatic. Multidisciplinary care involving maxillofacial surgeons, orthodontists, and other specialists may be recommended for comprehensive management.
Clinical Advice & FAQs
Billing Guidance
Is M26.71 a billable ICD-10 code?
Yes, M26.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M26.71?
Clinical documentation must specify the nature of Alveolar maxillary hyperplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference